Sponsored by Epicur Pharma® and Anivive
*Please note: this recording is not approved for CE credits
Genomic testing and precision medicine offer more hope than ever to the veterinary oncology patient. In this presentation, you will learn about cancer genomic testing for the veterinary patient and how tumor genetic biomarkers can guide and enhance diagnosis and treatment protocols. In addition, you will learn how genomics testing can offer better prognostic projections based on genetic mutations present in a particular tumor. Several case examples will be reviewed outlining results of SearchLight DNA testing and its implications in case management.
Dr. David Bruyette received his Doctor of Veterinary Medicine degree from the University of Missouri. Subsequently, he completed an internship at Purdue University and residency in internal medicine at the University of California-Davis. He was a staff internist at the West Los Angeles Veterinary Medical Group and a member of the Department of Comparative Medicine at Stanford University. Dr. Bruyette was an Assistant Professor and Head of Internal Medicine at Kansas State University and Director of the Analytical Chemistry Laboratory at Kansas State. He was Medical Director of the VCA West Los Angeles Animal Hospital, one of the largest 24-hour emergency/specialty practices in the country from Sept 1996 – Jan 2017. Dr. Bruyette is a diplomate of the American College of Veterinary Internal Medicine and a member of the Endocrine Society.
We have a full library of webinars and other resources to help you continue learning about the topics important to you, your practice, and your patients!